Android app Apple app link

Novo Nordisk A/S (NVO) Analyst Forecast

NYSE Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$48.70

$1.68 (-3.33%)
Last update: 02:39 PM EST
Day's range
$48.41
Day's range
$49.97

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
12/03/2025 Morgan Stanley Thibault Boutherin $42.00 $47.43   -11.45%
11/25/2025 BMO Capital Evan Seigerman $46.00 $44.97   2.29%
10/14/2025 BMO Capital Evan Seigerman $55.00 $57.50   -4.35%
07/23/2025 Truist Financial Jailendra Singh $48.00 $70.03   -31.46%
10/17/2024 BMO Capital Evan Seigerman $156.00 $118.58   31.56%
09/11/2024 Cantor Fitzgerald Louise Chen $160.00 $135.23   18.32%
08/08/2024 BMO Capital Evan David Seigerman $160.00 $126.17   26.81%
06/10/2024 Argus Research Jasper Hellweg $160.00 $142.88   11.98%
05/30/2024 Goldman Sachs James Quigley $156.00 $132.68   17.58%
04/12/2024 BMO Capital Evan David Seigerman $163.00 $125.40   29.98%

Novo Nordisk A/S FAQ's

Novo Nordisk A/S has been rated by research analysts at HSBC, Morgan Stanley, BMO Capital, Truist Financial, Cantor Fitzgerald, Argus Research in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.